|Home | About | Journals | Submit | Contact Us | Français|
Oleocanthal, a major phenolic compound in extra-virgin olive oil with anti-inflammatory properties, elicits an unusual oral pungency sensed almost exclusively in the throat. This contrasts with most other common oral irritants, such as cinnamaldehyde, capsaicin, and alcohol, which irritate mucus membranes throughout the oral cavity. Here we show that this rare irritation pattern is a consequence of both the specificity of oleocanthal for a single sensory receptor and the anatomical restriction of this sensory receptor to the pharynx, within the oral cavity. We demonstrate, in vitro, that oleocanthal selectively activates the hTRPA1 channel in HEK 293 cells and that its ability to excite the trigeminal nervous system in rodents requires a functional TRPA1. Moreover, we similarly demonstrate that the over-the-counter analgesic, ibuprofen, which elicits the same restricted pharyngeal irritation as oleocanthal, also specifically excites rodent sensory neurons via TRPA1. Using human sensory psychophysical studies and immunohistochemical TRPA1 analyses of human oral and nasal tissues, we observe an overlap of the anatomical distribution of TRPA1 and the regions irritated by oleocanthal in humans. These results suggest that a TRPA1 (ANKTM1) gene product mediates the tissue sensitivity to oleocanthal within the oral cavity. Further, we demonstrate that, despite the fact that oleocanthal possesses the classic electrophilic reactivity of many TRPA1 agonists, it does not use the previously identified activation mechanism via covalent cysteine modification. These findings provide an anatomical and molecular explanation for a distinct oral sensation elicited by oleocanthal and ibuprofen and that is commonly experienced around the world when consuming many extra-virgin olive oils.
The main source of fat in the Mediterranean diet is olive oil, the constituents of which play a central role in the diet’s health benefits (Perez-Jimenez et al., 2005). The beneficial constituents in olive oil include phenolic compounds (Carluccio et al., 2003). These phenolic compounds also underlie several of the noteworthy sensory characteristics of extra-virgin olive oils such as bitterness and a prized sensory attribute, an unusual pungency restricted to the throat that often leads to coughing and throat clearing. Indeed, high quality extra-virgin olive oils are sometimes referred to as “one cough” or “two cough oils” (the latter being more highly prized) because of this peculiar pungency. The only other compounds known to trigger this restricted pharyngeal irritation is the anti-inflammatory drug ibuprofen and its congeners (Breslin et al., 2001).
The principal molecule responsible for this pharyngeal pungency in extra-virgin olive oil is the phenolic compound (−)-oleocanthal (OC) [(−)-deacetoxy-dialdehydic ligstroside aglycone] (Andrewes et al., 2003) (Beauchamp et al., 2005). The reason why OC’s sensory characteristics are so distinctive is unknown. There are many well characterized oral irritants, especially from chili peppers and horseradish, but none have this unusually localized sensation.
Irritation sensations, such as the characteristic pharyngeal sting of OC, arise from stimulation of non-specialized nerve endings in the epithelium. Free nerve endings signal a wide range of endogenous and environmental stimuli such as protons, pressure, temperature, and nociceptive agents. The transient receptor potential (TRP) family of ion channels plays a prominent role in this signaling (Clapham, 2003). The thermoTRP channels (TRPV1-TRPV4, TRPM8 and TRPA1), in particular, are expressed in keratinocytes and primary sensory neurons of the nociceptive pathway responsible for sensations of irritation, and have been shown to participate in the transduction of pain induced by thermal, mechanical and chemical stimuli (Levine and Alessandri-Haber, 2007). Here we demonstrate that both OC and ibuprofen, selectively and robustly activate TRPA1, and we explain the mechanisms underlying the sensory properties of these compounds from human sensory, molecular and anatomical perspectives.
Rat and mouse trigeminal ganglia were collected from anesthetized animals (female and male used in equal ratio) under a protocol approved by the Institutional Animal Care and Use Committee of the Monell Chemical Senses Center and analyzed by Fura2/AM ratiometric calcium imaging. Neurons were dissociated in HBSS with trypsin (0.0625%) for 15 min, collagenase (1mg/ml) and DNase (0.1mg/ml) for 1 hour, and they were separated from myelin/debris using a 15/30/60% Percoll gradient. The neurons were plated on poly-l-lysine/laminin coated coverslips in modified neurobasal medium supplemented with B27, 100ng/ml NGF and kept at 37°C, 5 % CO2. Following 18 hour incubation, neurons were loaded with 5 µM Fura2 AM using 80 µg/ml F-127 Pluronic acid for 1 h. Intracellular calcium was measured ratiometrically using excitation at 340 and 380 nm and emission at 510 nm. During experiments, cells were continuously superfused with mammalian Ringer’s solution (containing 120 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 5 mM HEPES, pH 7.34) at 31–32°C into which solutions of test compounds were periodically introduced. The criterion used to determine a “response” to a stimulus is an increase of the average peak fluorescence amplitude > 0.2 units.
Human embryonic kidney-derived 293 (HEK293) cells were maintained in Dulbecco’s modified Eagle’s medium (supplemented with 10% fetal bovine serum, penicillin, streptomycin and L-glutamine) and transfected with 1 µg of human TRPA1 (gift from Dr. A. Patapoutian, The Scripps Institute, USA), human TRPV1 (from Dr. Y. Mori, Kyoto University, Japan), human TRPV2 (from Dr. S. Wakabayashi, National Cardiovascular Center Research Institute, Japan), human TRPV4 (from Dr. W. Leidtke, Duke University, USA), rat TRPV1, rat TRPV2, rat TRPM8 (from Dr. D. Julius, UCSF, USA), rat TRPV4, or mouse TRPV3 (from Dr. M. Caterina, John’s Hopkins University, USA) cDNA. One µg of expression vector and 0.1 µg pGreen Lantern 1 cDNAs in OPTI-MEM medium (Invitrogen Corp.) were transfected to HEK293 cells using Lipofectamine Plus Reagent (Invitrogen Corp.). After incubating for 3 to 4 h, cells were reseeded on coverslips and further incubated at 37°C in 5% CO2. One day after transfection, whole-cell patch-clamp recordings were performed. The standard bath solution for patch-clamp experiments contained (mM) 140 NaCl, 5 KCl, 2 MgCl2, 2 CaCl2, 10 HEPES, 10 glucose, pH 7.4 (with NaOH). The pipette solution contained (mM) 140 KCl, 5 EGTA, 10 HEPES, pH7.4 (with KOH). Data from whole-cell voltage-clamp recordings were sampled at 10 kHz and filtered at 5 kHz for analysis (Axon 200B amplifier with pCLAMP software, Axon Instruments). The voltage-ramp pulse (400 ms) from −100 mV to +100 mV was applied to the patch-clamped cell held at −60 mV every 5 second. Whole-cell patch-clamp recordings were performed one day after transfection of HEK293 cells. All the experiments were performed at room temperature.
A double cysteine mutant of mouse TRPA1 (C422S/C622S) was generated by cysteine-serine substitutions at C422 and C622, residues which are thought to be covalently modified by several electrophilic agonists, in the N terminal domain. These mutations were made by using a modified Quickchange Site-directed Mutagenesis method (Stratagene, La Jolla, CA). Briefly, PCR was performed using two residues of mouse TRPA1 expression vector divided at the Cla I (New England Biolabs, Beverly, MA) site as templates (the former for C422S, the latter for C622S), two synthetic oligonucleotide primers containing specific mutations (C422S-S and AS, 5’-CATTATGCCTCTAGGCAGGGG-3’ and 5’-CCCCTGCCTAGAGGCATAATG-3’, C622S-S and AS, 5’-CCCGAGTCCATGAAAGTTCTT-3’ and 5’-AAGAACTTTCATGGACTCGGG-3’), and primestar™ HS DNA polymerase (TAKARA, Kusatsu, Japan). The PCR products were digested with Dpn I (New England BioLabs, Beverly, MA) at 37 °C for one hour, and transformed into DH5a competent cells. The entire sequence including desired substitution in the mutants was confirmed. TRPA1 mutant (C422S/C622S) was constructed by combining these two mutants at the Cla I site.
Under protocols approved by the Office of Regulatory Affairs at the University of Pennsylvania, volunteers were asked to evaluate the irritation elicited by the test compounds using a computerized general Labeled Magnitude Scale (gLMS) (Green et al., 1996). On this gLMS, subjects rated the perceived intensity along a vertical axis lined with adjectives: barely detectable = 1, weak = 5, moderate = 16, strong = 33, very strong = 51, strongest imaginable = 96. The gLMS only shows adjectives, not numbers, to the subjects, but the experimenter receives numerical data from the computer program. Each subject was tested only twice a day with one sample and with at least 2 hours separating each test (Brand and Jacquot, 2002). All tests were performed in duplicate and stimuli were presented in random order.
For testing irritation on the tongue, subjects immersed their tongue into a medicine cup containing 25 ml of solution for 45 seconds. For testing irritation in the throat, the same subjects placed 3.5 ml of the solutions in their mouth, holding it for 3 seconds and then swallowing it. After 45 sec, subjects were asked to rate the peak throat irritation intensity. For testing irritation in the nose, subjects (n =14) applied 0.3 ml of the test stimuli dissolved in saline solution (SaltAire sinus relief) with a metered nasal spray device (Total Pharmacy Supply, TX). After 30 seconds, subjects were asked to rate the peak nasal irritation intensity on the gLMS.
The biopsy of fungiform papillae from the front-edge of 3 healthy volunteers’ tongues and the nasal biopsies from middle turbinate of 4 other healthy volunteers were excised under protocols approve by the Office of Regulatory Affairs at the University of Pennsylvania. Additionally, fresh human tongue and pharyngeal tissue were obtained from the cadaver of an accident victim, who was healthy prior to the accident (a non clinical patient), and were provided by National Disease Research Interchange (Philadelphia, USA). Thus, tissues that are OC-sensitive and OC-insensitive were obtained from 8 different individuals for immunohistochemical analysis of TRPA1 expression in sensory neurons. All tissues were fixed in 4% paraformaldehyde in phosphate buffer saline (PBS) for 1–2 hours, then cryoprotected in sucrose series. The entire biopsies were cut into 10 µm sections and placed onto Starfrost Adhesive slides (Mercedes Medical) and stored at −30°C. Slides were removed from −30°C and dried at 40°C for 20 min, then they were washed 1 time for 10 minutes in 10 mM, pH 7.4, phosphate-buffered saline (PBS). To block nonspecific binding, sections were incubated in RT with SuperBlock blocking buffer (Pierce #37517) overnight. Then, sections were incubated with primary antibody diluted in 10% SuperBlock for 2 days at 4°C in humidified chamber followed by secondary Ab conjugated to fluorescence probe (Alexa Fluor 488 goat anti-mouse IgG or Alexa Fluor 633 goat anti-rabbit IgG, Molecular Probes Lab) in 1% SuperBlock for 1 hour at room temperature. The sections then were washed twice with PBS followed with milliQ water, then mounted with Vectorshield or Vectorshield with DAPI (Vector Laboratories, Burlingame, CA). Control experiments were performed using an excess of the appropriate homolog peptide antigen to absorb the primary antibodies and thus confirm a specific immunoreaction. Antibodies used included Anti-Human TRPA1 polyclonal made in rabbit, dilution 1:100; (from MBL, # LS-A9097), and monoclonal Anti-Human PGP9.5 made in mouse (AbD Serotec), or monoclonal Anti-Syntaxin made in mouse (Sigma). Images were taken using a Leica TCS SP2 Spectral Confocal Microscope (Leica Microsystems Inc., Mannheim, Germany). Quantification of TRPA1 antibody fluorescence was evaluated by counting positives cells on analyzed slides for which surface area of tissues was determined with the confocal microscope software. TRPA1 quantification is expressed as number of cells per mm2.
All the compounds were purchased at Sigma-Aldrich (St. Louis, MO), except HC-030031 which was obtained from ChemBridge (San Diego, CA) and oleocanthal and analogues which were synthesized as described in References (Smith et al., 2005; Smith et al., 2007).
Data in figures are presented as mean ± SEM (standard error of the mean). Statistical significance was evaluated using Student's unpaired t-tests. Statistical significance was set at P value <0.05.
We first examined whether OC directly excites primary sensory neurons by using Fura-2 ratiometric calcium imaging on acutely cultured rat trigeminal ganglion neurons. Application of OC elicited robust calcium influx (Fig. 1a) into approximately 30 % of the trigeminal neurons, in a concentration-dependent manner (Fig. 1b). Comparison of OC’s trigeminal neuron activation profile (distribution and intensity of intracellular calcium influx) with more commonly employed oral irritants such as menthol, AITC or capsaicin, which stimulate TRPM8 (McKemy et al., 2002; Peier et al., 2002), TRPA1 (Bandell et al., 2004; Jordt et al., 2004) and TRPV1 (Caterina et al., 1997) receptors respectively, demonstrated that the populations of rat neurons robustly activated by OC were sensitive to AITC (50 µM) and the magnitude of the calcium influx elicited by these stimuli were tightly correlated (Fig. 1c), whereas no correlation was observed with other irritant response profiles (Supporting Information (SI) Fig. 1). Using the response criterion of a change of peak fluorescence amplitude greater than 0.2 units, in these experiments, 100 % of the AITC-sensitive neurons responded to OC and only 30 % of the capsaicin-sensitive neurons responded to OC.
To test the hypothesis that OC acts on the TRPA1 ion channel in trigeminal neurons, we used the selective TRPA1-blocker HC-030031 (McNamara et al., 2007) and additionally examined the response profiles of trigeminal neurons from TRPA1-deficient (knock-out) mice. OC-evoked calcium increases were totally abolished by 20 µM HC-030031 and neurons from TRPA1 null (−/−) mice were utterly unresponsive to OC (Fig. 1d). As expected, in both experiments the sensitivity to capsaicin was retained (SI Fig. 2). The complete loss of sensitivity to OC implicates TRPA1 as the requisite native target in sensory neurons.
To confirm the activation and specificity of OC on TRPA1, we used patch-clamp recordings and calcium imaging on heterologously expressed TRP channels. All the known thermoTRP channels (TRPV1-TRPV4, TRPM8 and TRPA1) which are involved in irritation transduction were tested. OC induced robust currents in HEK-293 cells expressing the human TRPA1 channel (Fig. 2a), in the presence or absence of external calcium, but not in human TRPV1, TRPV2 and TRPV4 (Fig. 2b). OC also did not excite HEK cells expressing rodent TRPV1, 2, 3, 4, and TRPM8 (SI Fig.3). We established the EC50 of OC at 2.8 µM in hTRPA1 and verified that OC-elicited currents were reversibly inhibited by the TRPA1 blocker HC-030031 (SI Fig. 4). Thus OC’s neuronal signal is transduced by TRPA1 and no other thermoTRP channels.
The phenylpropanoic non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen (IBU), trigger a pharyngeal irritation remarkably similar in quality and restricted location to that elicited by OC (Breslin et al., 2001). Demonstration that IBU, like OC, selectively activates TRPA1 in sensory neurons would reinforce the hypothesis that this receptor mediates the unusual restricted pharyngeal pungency in vivo. Application of IBU (10 mM) elicited robust calcium influx into cultured trigeminal neurons (Fig. 3a) in a concentration-dependent manner (Fig. 3b). Unfortunately, the high IBU concentrations (> 30 mM) required to complete the dose-response curve presented in Fig. 3b did not permit us to reach saturation, as the increase of the ionic strength and osmolarity of the medium affected cell viability. It is worth noting that all dissociated trigeminal neurons exposed to IBU showed some small intracellular calcium increase, dependent on the presence of extracellular calcium, (Fig. 3c, grey circle). But robust responses to IBU (with peak magnitudes greater than 0.2 units) were only observed in neurons that responded to OC. Also, the magnitudes of activation by these two compounds were correlated (Fig. 3c). This suggests that OC and IBU act on the same receptor(s). Comparable to OC, the selective TRPA1 blocker HC-030031 (20 µM) strongly suppressed the intracellular calcium increase induced by 10 mM IBU that occurred in the OC-sensitive neurons. Only the low level basal calcium influx induced by IBU, ubiquitously found in all the neurons, and not considered a true response (peak magnitude mean < 0.2 units), remained (Fig. 3e, left). Similar results were obtained with TRPA1-deficient trigeminal neurons from knock-out mice (Fig. 3e, right). These results strongly suggest that IBU elicits neuronal responses by acting on TRPA1, but the data are less clear than with OC. In order to confirm that TRPA1 is required for IBU-evoked neuronal response we conducted current measurements in sensory neurons (Dorsal root ganglion, DRG, neurons). The data in Figure 3d show that when TRPA1 is absent (AITC insensitive), the sensory neuron is not activated. Indeed, there is no current recorded after IBU exposure (Figure 3d bottom). Whereas when TRPA1 is present (AITC positive), the sensory neuron is activated by IBU (Figure 3d top). In total, 20 sensory neurons have been tested. These results confirm that IBU selectively activates TRPA1 (directly or indirectly) and no other receptor in sensory neurons.
In patch-clamp recordings and calcium imaging on heterologously expressed TRP channels, IBU induced robust currents in HEK-293 cells expressing human TRPA1 channel (Fig. 4a) in the presence or absence of external calcium, and had no or little effect on HEK cells expressing human TRPV1, TRPV2, TRPV4 (Fig. 4b) and rodent TRPM8 and TRPV1-4 (SI Fig.3). In summary, these results support the conclusion that, OC and IBU’s orosensory signals are mediated via the same receptor, TRPA1.
Most pungent food products elicit strong sensation throughout the oral cavity, these include the plant-derived oral irritants such as isothiocyanates (mustard, winter cress), allicin (garlic), cinnamaldehyde (cinnamon bark), carvacrol (oregano) or thymol (thyme), which are all TRPA1 agonists (Bandell et al., 2004; Jordt et al., 2004; Bautista et al., 2005; Macpherson et al., 2005; Xu et al., 2006; Lee et al., 2008). There are a few possibilities as to why irritation from these stimuli is not restricted to the throat in humans as it is for OC and ibuprofen. One is that the perceptual differences between OC and other TRPA1 agonists are the result of differences in stimulus concentrations. Indeed these irritating compounds are experienced in foods at higher concentrations (mM) than the OC concentrations found in extra-virgin olive oil (100 to 700 µM). To test this hypothesis, we compared the irritation sensation characteristics of a commercial extra-virgin olive oil with those of a horseradish solution (1.25 g dissolved in 100 ml milliQ water), both sources of TRPA1 agonists (OC and AITC respectively). Human subjects (n=12), while wearing nose clips to block odors and nasal irritation, were asked to rate the irritation perceived on their anterior tongue after immersing it in 25 ml of either extra-virgin olive oil (Badalucco) or horseradish (wasabi, S&B) solution, and the irritation perceived in their throat after swallowing 3.5 ml of the same solutions. Although the two solutions triggered pharyngeal irritation with matching intensity, extra-virgin olive oil elicited very little pungency on the anterior tongue while horseradish irritation was strongly sensed on anterior tongue (Fig. 5a). Thus, it is unlikely that OC’s weaker anterior oral pungency compared to AITC is due to concentrations being insufficient to stimulate strong oral pungency. The two irritants in these food products elicit very different sensory profiles although they both act on TRPA1 with comparable sensory EC50 values: OC (2.8 µM for hTRPA1) and AITC (11.3 µM for hTRPA1) (Chen et al., 2008).
We also determined that the viscous and hydrophobic nature of olive oil does not prevent OC from acting in the mouth by comparing the irritation location of OC dissolved in water with the irritation location of OC dissolved in corn oil. For this study, the OC concentration was set at 660 µM, which corresponds to the very high end of what can be found in commercial extra-virgin olive oils (Beauchamp et al., 2005). The addition of 0.25 % ethanol was required to dissolve the OC in water. Because ethanol itself may be irritating at this concentration we included a control aqueous solution containing 0.25 % ethanol only. Following the same protocol as the sensory study above, subjects (n=13) rated the intensity of the irritation perceived either on the tip of the tongue or in the throat. As was the case for extra-virgin olive oil, OC predominantly triggered irritation in the throat compared to the anterior tongue and did this independently of the medium in which the compound was dissolved (Fig. 5b). Although it appears that OC dissolved in water elicited slight irritation on the anterior tongue, this was not significantly greater than that elicited by the alcohol vehicle control (t-test, p > 0.05). The perceived anterior lingual irritation is, thus, likely due to the presence of ethanol. That OC regional irritation properties are also observed in aqueous medium is consistent with previous observations with IBU in aqueous mixtures (Breslin et al., 2001).
Another explanation for the absence of oral pungency from OC in anterior tongue could be an inability of this compound to stimulate the human trigeminal nerve. To address this hypothesis, we asked subjects (n=11) to evaluate nasal irritation from OC and IBU when they were sprayed into the nare, since nasal irritants are detected solely by trigeminal nerve endings. Cinnamaldehyde and sucrose were also tested, as positive and negative controls respectively for irritation sensation (Fig. 5c). As expected, sucrose solutions did not elicit irritation and cinnamaldehyde triggered concentration-dependent nasal irritation. OC and IBU induced irritation in the nose that increased monotonically with concentration, which demonstrates that they clearly activate the human trigeminal nerve in situ. Note that 60 µM OC elicited moderate irritation in the nose (based on sensory ratings on a general Labeled Magnitude Scale), which is approximately ten-fold more sensitive than the throat (Beauchamp et al., 2005). Concentrations at which humans perceive nasal irritation elicited by OC are very similar to the concentrations required to activate rat trigeminal neurons and hTRPA1 channels expressed in HEK-293 cells (1–60 µM) (Fig. 5d). Hence, OC excites the human sensory neural system with high potency in nasal and pharyngeal tissues, and the absence of anterior oral pungency from OC is not due to a failure to act on trigeminal neurons in humans.
We hypothesized that the specific OC-responsive TRPA1 channel may be expressed less in the mandibular branch of the trigeminal nerve that innervates the anterior tongue than in nasal and pharyngeal branches. We immunohistochemically assessed TRPA1 expression in human tongue biopsies from four volunteers, in nasal biopsies from four different subjects, and in pharyngeal tissue from one subject, who also provided a tongue biopsy. In total, healthy tissues from eight subjects were analyzed for TRPA1 expression in sensory neurons of OC-sensitive tissues (nasal and pharyngeal) and OC-insensitive tissue (anterior tongue). Antisera-raised against human TRPA1 in rabbits was used on human lingual fungiform papilla (Fig. 6 a–f) and pharyngeal epithelium (Fig. 6 g–l). Antibodies to the generic neural marker PGP9.5 indicated that both epithelia are richly innervated with free nerve endings (Fig. 6 d–j). In particular, taste buds are densely innervated and are surrounded by trigeminal neural fibers passing through the epithelium in the peri-bud region, but none of these fibers demonstrated TRPA1 immunoreactivity upon double labeling (Fig. 6f, and SI Fig. 5 for large scale fungiform papilla). In contrast, neuronal cells from human upper pharynx showed clear TRPA1 double immunoreactivity with the neural marker PGP9.5 (Fig. 6l). 8 to 10 slides were examined for each tissue type. For pharyngeal tissue, 80 TRPA1 positive cells/ 0.12 mm2 (mean) were observed, and for lingual tissue (taste buds), 0 TRPA1 positive cells/ 0.05 mm2 (mean). Immunohistochemistry performed on four humans’ nasal epithelia, another tissue highly sensitive to OC irritation, led to similar results as seen in the pharynx (SI Fig. 6). TRPA1 antibody specificity was demonstrated in human tissues either treated with secondary antibodies in the absence of primary antibodies or treated with TRPA1 antibodies blocked with the TRPA1 peptide (SI Fig. 6). In addition, TRPA1 null (−/−) mice epithelium displayed minimal antibody reactivity compared to wild-type mouse lingual tissues, further supporting specificity of this TRPA1 antibody for the target protein (SI Fig. 7). [Note that unlike humans, mice express TRPA1 robustly in lingual tissues.] These observations suggest a poor expression of the OC receptor on the trigeminal fibers innervating the human anterior tongue compared with human pharyngeal and nasal nerve afferents. This antibody reveals a TRPA1 anatomical distribution that overlays with the profile of localized sensory irritation observed with OC in humans. These results also suggest that some canonical TRPA1 agonists, such as AITC, may irritate the anterior tongue in humans via interaction with a TRPA1 variant that does not react with our TRPA1 antibody or possibly via interaction with other irritant receptors.
To understand how OC might differ from other TRPA1 agonists with regard to the high specificity for TRPA1, we performed receptor mutagenesis and structure-activity studies. TRPA1 agonists can be divided into two basic categories related to their reactivity: electrophiles, such as AITC (Jordt et al., 2004) and many α,β-unsaturated aldehydes (Macpherson et al., 2007b; Trevisani et al., 2007), and non-electrophiles, such as carvacrol (oregano) (Xu et al., 2006). Electrophilic agonists activate TRPA1 through covalent modification of cysteine residues located within the N-terminal cytoplasmic domain of the receptor (Hinman et al., 2006; Macpherson et al., 2007a) and, to a lesser extent, through covalent binding to lysine residues (shown for AITC) (Hinman et al., 2006). The mechanism of TRPA1 activation by non-electrophilic agonists is presently unknown. OC is electrophilic and its structure contains a phenol ring. We asked which structural features of OC contribute to its sensory activity. We conducted Structure Activity Relationship (SAR) studies with synthetic oleocanthal analogues (Smith et al., 2007) using calcium imaging on dissociated rat trigeminal neurons (Fig. 7a). We found (Fig. 7b) that the saturation of the double bond dramatically decreased the potency of the molecule (A12) and, importantly, that both aldehyde groups are required to maintain OC activity (see analogues A10, 9 and 14). Although A9 is an α,β unsaturated aldehyde, and for this reason was expected to maintain sensory activity through cysteine modification of TRPA1 like other electrophilic agonists, no intracellular calcium increase was observed at 5 µM.
We confirmed by LC-MS and NMR analyses (SI Fig.8) that OC is capable of forming adducts to cysteine, primarily through its α,β unsaturated aldehyde moiety, but this feature does not enable OC to activate TRPA1, which distinguishes it from AITC and cinnamaldehyde.
To verify the hypothesis that OC does not activate TRPA1 via cysteine modification, we tested OC activity on a TRPA1 mutant rendered insensitive or weakly sensitive to electrophilic agonists, via substitution of two reactive cysteines (C422 and C622) by non-reactive residues (serine). Whereas cinnamaldehyde and AITC activities were abolished or strongly impaired in cells expressing the serine-substituted TRPA1 mutant, OC induced robust currents, similar to those evoked in wild-type TRPA1 expressing cells (Fig. 7c; see also (Escalera et al., 2008) for parallel results). These data confirm that OC activates the ion channel via a mechanism different from most electrophilic TRPA1 agonists, which may explain the high specificity of OC for the TRPA1 receptor expressed in pharynx and nose identified by our antibody. .
OC triggers an unusual irritation in the pharynx when ingested. Unlike most known chemical irritants, OC does not significantly irritate the oral cavity; instead, the sting is restricted to the upper airways and is often accompanied by throat clearing and coughing. Our goal in this work was to understand the molecular and physiological basis for this unique pungency. We show here that OC, as well as ibuprofen, another compound whose irritancy is primarily restricted to the throat, activate the ion channel hTRPA1 ex vivo, and their ability to excite the trigeminal nervous system depends upon functional TRPA1 in sensory neurons. Our perceptual studies in humans show that OC triggers irritation in the throat and nasal cavities with high potency compared to the anterior tongue. Consistent with the hypothesis that the OC sensory properties in vivo are the result of TRPA1 activation, immunohistochemical imaging of human tissues with hTRPA1-specific antibodies revealed poor reactivity in neural fibers of the anterior tongue relative to the reactivity in neural fibers of the sensitive pharyngeal and nasal epithelia.
Previous perceptual studies have indicated that the oral mucosae along the rostrocaudal axis are not uniformly sensitive to chemical irritants (Rentmeister-Bryant and Green, 1997). The problem is that in vitro neural studies of primary sensory neurons derive largely from analysis of complete neuronal populations prepared from whole sensory ganglia such as the trigeminal ganglion. Thus, different functional properties of primary trigeminal afferents from the different sub-regions of the face remain largely uninvestigated. Using a viral tracing technique to identify nasal and cutaneous cultured mouse trigeminal neurons, Damann et al. observed a larger fraction of nasal trigeminal neurons exhibiting sensitivity for menthol and capsaicin. This indicates that neurons expressing TRPM8 and TRPV1 are not equally distributed among trigeminal fibers innervating different regions of the mouse head (Damann et al., 2006). In a comparable fashion, we showed heterogeneity of TRPA1 channel expression in human trigeminal afferents with poor expression of TRPA1 in the mandibular branch. Previous immunohistochemical studies have shown the presence of TRPA1 channel in nerve bundles of mouse tongues ((Nagatomo and Kubo, 2008), in the human lingual nerve ((Morgan et al., 2009). TRPA1 mRNAs have also been identified in the mandibular branch of the trigeminal nerve in mouse ((Kobayashi et al., 2005). To our knowledge, however, the expression of TRPA1 channels on neuronal fibers innervating the human anterior tongue have not been reported.
As demonstrated, the concentration differences among compounds are unlikely to account for the pattern of OC irritation. Lipophilicity, and hence access to nerve fibers, also does not account for the differences in anterior tongue sensations, as AITC and OC have comparable partition coefficients. Moreover, OC is similarly effective in water and in oil. That irritation from other TRPA1 agonists is not restricted to the throat is consistent with a higher specificity of OC to the hTRPA1 channel we assessed. We demonstrated that OC does not bind to the ‘traditional’ cysteine residues of TRPA1 that are required for cinnamaldehyde and AITC activation of TRPA1. In addition, we showed that OC differs from these other agonists in that OC requires both aldehyde groups to activate TRPA1. The selectivity for the TRPA1 channel highly expressed in nasal and pharyngeal tissues is thus likely explained by differences in how OC interacts with the channel. Thus, the high specificity of OC for this receptor and the restricted expression pattern of the receptor underlie the unusual pungency of extra-virgin olive oil.
Our explanation for these observations is consistent with other data on receptor specificity. Many compounds presumed to be specific to a given TRP channel have subsequently been shown to activate other TRP channels involved in irritation transduction (Macpherson et al., 2006). For example, allicin can activate TRPV1 in addition to TRPA1 (Macpherson et al., 2005; Salazar et al., 2008), and cinnamaldehyde, carvacrol and thymol are also TRPV3 agonists (Macpherson et al., 2006; Xu et al., 2006; Lee et al., 2008). In several studies, AITC-activated sensory neurons have been shown to be more numerous than those stimulated by other TRPA1 agonists such as zinc (Hu et al., 2009) or cinnamaldehyde (Bandell et al., 2004) and AITC specificity toward TRPA1 has been previously questioned (Bandell et al., 2004; Kwan et al., 2006). AITC has also been reported to activate porcine pTRPV1 at concentrations (mM) found in food products (Ohta et al., 2007). Therefore, it is possible that sensory receptor(s) other than the hTRPA1 protein we assessed, possibly a splice variant of TRPA1, contribute to the anterior oral pungency evoked by AITC and other canonical TRPA1 ligands in humans.
What is the functional or ecological significance of the pungency to the human upper airways? One explanation is that the posterior location of toxin and irritant detectors can protect against their intake either by inhalation or ingestion. Many bitter tasting toxins are perceived more strongly in the posterior oral cavity than the anterior (Danilova and Hellekant, 2003). For instance, the bitter iso-α-acids from hop cone flowers found in beers stimulate taste receptors almost exclusively in the pharynx. Detection in the posterior mouth guards against intake of toxins and irritants at the last possible checkpoint. Many air pollutants such as acrolein are TRPA1 agonists (Bautista et al., 2006) and will elicit cough. Like TRPV1, TRPA1 has been shown to be expressed both in the upper and the lower airways (Fajardo et al., 2008; Nassenstein et al., 2008). Thus, TRPA1 is well positioned to protect the lungs by triggering defensive cough responses to reactive agents (Bessac and Jordt, 2008; Taylor-Clark et al., 2008).
But if the role of these ion channels is to protect tissue from harmful compounds, then it is a mystery how the TRPA1-mediated throat irritation of extra virgin olive oils came to be valued as a positive sensory attribute by those who consume them. Indeed, this pungency is an important quality that distinguishes particularly good olive oils in the European Union standards. Similarly, other common food irritants (e.g. capsaicin, menthol, AITC and so forth) are also important positive components in many cuisines, so this is a very general question. Pungency is believed to signal potentially harmful compounds in our food but consumption of many compounds eliciting this sensation is also linked to decreased risks of cancer and degenerative and cardiovascular diseases (Boyd et al., 2006; Peng and Li, 2010). Oleocanthal has been shown to be a potent anti-inflammatory agent (Beauchamp et al., 2005), implicating potential medicinal value to this compound. It is, therefore, perhaps no coincidence that the only other known restricted throat irritants are NSAID molecules such as ibuprofen. At least in the case of extra-virgin olive oils, we suggest that by a process not yet well understood people have come, perhaps unconciously, to transform an inherently unpleasant sensation into a positive one because it has beneficial health effects (Peyrot des Gachons et al., 2009). This broad speculation requires considerably more investigation before it can be demonstrated.
Thanks to N. Rawson and K. Yee for assistance with nasal biopsy tissue and H. Ozdener for help with immunohistochemistry experiments. We also thank K. Plank for assistance with mouse colony maintenance. Research supported by NIH DC02995 (PASB), NIH DC006760 (PASB & GKB) and NIH GM29028 (ABS III). JBS was supported by an NIH, Ruth L. Kirschstein NRSA (FCA121716A). Confocal microscopy supported by NSF-DBI-0216310 (N. Rawson). TRPA1 knock out mice were generously provided by David Corey and Kelvin Kwan from Harvard University. The following reagents were provided as gifts: human TRPA1 (gift from Dr. A. Patapoutian, The Scripps Institute, USA), human TRPV1 (from Dr. Y. Mori, Kyoto University, Japan), human TRPV2 (from Dr. S. Wakabayashi, National Cardiovascular Center Research Institute, Japan), human TRPV4 (from Dr. W. Leidtke, Duke University, USA), rat TRPV1, rat TRPV2, rat TRPM8 (from Dr. D. Julius, UCSF, USA), rat TRPV4, or mouse TRPV3 (from Dr. M. Caterina, John’s Hopkins University, USA).